Pathfinder Cell Therapy, Inc.

PFND · OTC
Analyze with AI
$0.0001+$0.00 (+0%)
At close:Dec 17, 2025, 9:00 PM UTC
P/E TTM-0.04
P/B TTM-0.01
P/S TTM0
Dividend Yield0%
EPS
Beta-24.332
Valuation
PEG Ratio-0.00
FCF Yield-1,443.43%
EV / EBITDA-4.50
Quality
ROIC116.56%
Gross Margin0.00%
Cash Conv. Ratio0.54
Growth
Revenue 3Y CAGR-100.00%
FCF Growth39.85%
Safety
Net Debt / EBITDA-4.44
Interest Coverage0.00
Efficiency
Inventory Turnover0.00
Cash Conv. Cycle0.00

Pathfinder Cell Therapy, Inc. (PFND) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is Pathfinder Cell Therapy, Inc. (PFND) stock price today?

As of Dec 17, 2025, 9:00 PM UTC, Pathfinder Cell Therapy, Inc. (PFND) stock is trading at $0.0001. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date PFND stock quotes for informed trading decisions.

What is Pathfinder Cell Therapy, Inc.'s market capitalization?

Pathfinder Cell Therapy, Inc. (PFND) has a market capitalization of approximately $66.7K. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Pathfinder Cell Therapy, Inc.'s size relative to other companies in the USD market. The market cap figure updates automatically as the PFND stock price changes.

What is the 52-week range for Pathfinder Cell Therapy, Inc. stock?

Pathfinder Cell Therapy, Inc. (PFND) stock has traded in a 52-week range of $0.00 — $0.0001. The 52-week range shows the highest and lowest prices at which PFND traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Pathfinder Cell Therapy, Inc. stock price to this range provides context for recent price action.

How much trading volume does Pathfinder Cell Therapy, Inc. stock have?

Pathfinder Cell Therapy, Inc. (PFND) stock recently traded approximately 500 shares. Trading volume indicates market liquidity and investor interest in PFND. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Pathfinder Cell Therapy, Inc. stock.

Does Pathfinder Cell Therapy, Inc. pay dividends to shareholders?

Yes, Pathfinder Cell Therapy, Inc. (PFND) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Pathfinder Cell Therapy, Inc. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Pathfinder Cell Therapy, Inc.'s intraday price range?

Today, Pathfinder Cell Therapy, Inc. (PFND) stock has traded in a range of $0.00 — $0.0001. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring PFND's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Pathfinder Cell Therapy, Inc. stock data?

AlphaPilot sources real-time PFND stock quotes, fundamental financial data, and historical price charts for Pathfinder Cell Therapy, Inc. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Pathfinder Cell Therapy, Inc. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of PFND stock performance.